Sonoma pharmaceuticals celebrates 20 years of selling wound care products in europe and announces new distributor in ukraine

Boulder, co / accesswire / july 9, 2024 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announces it is celebrating its 20th anniversary of selling wound care products in europe. sonoma is also proud to announce that it is expanding its distributor base in europe by adding a new partnership with smart healthcare company (shc) s.r.o.
SNOA Ratings Summary
SNOA Quant Ranking